Floatz logo

MANNITOL

Intracranial Hypertension

University Hospital, GrenobleSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Intracranial Hypertension cohort.

Asset / SponsorPhaseRating
CISATRACURIUM ION
University Hospital, Clermont-Ferrand
Phase 4BB
Bxcl501
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
FENTANYL
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
MIDAZOLAM
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
PROPOFOL
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB

View all 11 →

Same molecule, other indications

MANNITOL is also rated in:

cystic fibrosisDormant
BB
Indicative ·
69 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
65 / 100
View asset →
Short Bowel SyndromeDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →